CoChat

Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8 + Cells

Open access
Fridlender, Zvi G., Kapoor, Veena, Buchlis, George, Cheng, Guanjun, Sun, Jing, Wang, Liang-Chuan S., Singhal, Sunil, Snyder, Linda A., Albelda, Steven M. · 2011 · American Journal of Respiratory Cell and Molecular Biology
Cited by 147

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The role of chemokines in the pathogenesis of lung cancer has been increasingly appreciated. Monocyte chemoattractant protein-1 (MCP-1, also known as CCL2) is secreted from tumor cells and associated tumor stromal cells. The blockade of CCL2, as mediated by neutralizing antibodies, was shown to reduce tumorigenesis in several solid tumors, but the role of CCL2 in lung cancer remains controversial, with evidence of both protumorigenic and antitumorigenic effects. We evaluated the effects and mechanisms of CCL2 blockade in several animal models of non-small-cell lung cancer (NSCLC). Anti-murine-CCL2 monoclonal antibodies were administered in syngeneic flank and orthotopic models of NSCLC. CCL2 blockade significantly slowed the growth of primary tumors in all models studied, and inhibited lung metastases in a model of spontaneous lung metastases of NSCLC. In contrast to expectations, no significant effect of treatment was evident in the number of tumor-associated macrophages recruited into the tumor after CCL2 blockade. However, a change occurred in the polarization of tumor-associated macrophages to a more antitumor phenotype after CCL2 blockade. This was associated with the activation of cytotoxic CD8(+) T lymphocytes (CTLs). The antitumor effects of CCL2 blockade were completely lost in CB-17 severe combined immunodeficient mice or after CD8 T-cell depletion. Our data from NSCLC models show that CCL2 blockade can inhibit the tumor growth of primary and metastatic disease. The mechanisms of CCL2 blockade include an alteration of the tumor macrophage phenotype and the activation of CTLs. Our work supports further evaluation of CCL2 blockade in thoracic malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1165/rcmb.2010-0080oc

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 44

  1. 2006, Clin Cancer Res, 12, 4794, 10.1158/1078-0432.CCR-06-0944 · DOI
  2. 2007, Annu Rev Immunol, 25, 267, 10.1146/annurev.immunol.25.022106.141609 · DOI · Paper page
  3. 2004, Semin Cancer Biol, 14, 149, 10.1016/j.semcancer.2003.10.009 · DOI · Paper page
  4. 2007, Neoplasia, 9, 556, 10.1593/neo.07307 · DOI · Paper page
  5. 2008, Cancer Immunol Immunother, 57, 123, 10.1007/s00262-007-0336-x · DOI · Paper page
  6. 1997, Cancer Res, 57, 4849
  7. 2005, Blood, 106, 3322
  8. 2007, Immunol Lett, 113, 19, 10.1016/j.imlet.2007.07.004 · doi:10.1016/j.imlet.2007.07.004
  9. 2007, Cancer Res, 67, 9417, 10.1158/0008-5472.CAN-07-1286 · DOI · Paper page
  10. 2009, Neoplasia, 11, 228, 10.1593/neo.81282 · DOI · Paper page
  11. 2000, Cancer Immunol Immunother, 49, 63, 10.1007/s002620050603 · DOI
  12. 1998, Cancer Immunol Immunother, 47, 72, 10.1007/s002620050506 · DOI
  13. 2000, Cancer Res, 60, 7002
  14. 1997, J Exp Med, 185, 99, 10.1084/jem.185.1.99 · DOI · Paper page
  15. 2007, Hum Antibodies, 16, 117
  16. 1996, Cancer Res, 56, 21
  17. 2005, Cancer Res, 65, 8379, 10.1158/0008-5472.CAN-05-0920 · DOI
  18. 1994, Growth Factors, 11, 29, 10.3109/08977199409015049 · DOI · Paper page
  19. 2003, J Immunol, 171, 5051, 10.4049/jimmunol.171.10.5051 · DOI · Paper page
  20. 2010, Cancer Res, 70, 109
  21. 2006, Clin Cancer Res, 12, 214, 10.1158/1078-0432.CCR-05-1178 · DOI
  22. 2005, Clin Cancer Res, 11, 6713, 10.1158/1078-0432.CCR-05-0883 · DOI · Paper page
  23. 1998, J Exp Med, 187, 601, 10.1084/jem.187.4.601 · DOI · Paper page
  24. 2006, J Clin Invest, 116, 2132, 10.1172/JCI27648 · DOI · Paper page
  25. 2008, J Leukoc Biol, 84, 679, 10.1189/jlb.1107729 · DOI
  26. 2007, J Immunol, 179, 3332, 10.4049/jimmunol.179.5.3332 · DOI · Paper page
  27. 2008, J Immunol, 180, 2886, 10.4049/jimmunol.180.5.2886 · DOI
  28. 2001, J Immunol, 166, 6483, 10.4049/jimmunol.166.11.6483 · DOI · Paper page
  29. 2009, Cancer Res, 69, 1685, 10.1158/0008-5472.CAN-08-2164 · DOI · Paper page
  30. 2008, Immunol Rev, 222, 155, 10.1111/j.1600-065X.2008.00607.x · DOI · Paper page
  31. 2006, Neoplasia, 8, 578, 10.1593/neo.06280 · DOI · Paper page
  32. 2000, Blood, 96, 34, 10.1182/blood.V96.1.34 · DOI · Paper page
  33. 2002, J Lab Clin Med, 140, 320, 10.1067/mlc.2002.128317 · DOI · Paper page
  34. 2005, Cancer Res, 65, 11752, 10.1158/0008-5472.CAN-05-1658 · DOI · Paper page
  35. 2005, J Cancer Res Clin Oncol, 131, 453, 10.1007/s00432-004-0667-3 · DOI
  36. 2009, J Biol Chem, 284, 34342, 10.1074/jbc.M109.042671 · DOI · Paper page
  37. 2005, J Immunol, 175, 4583, 10.4049/jimmunol.175.7.4583 · DOI · Paper page
  38. 2007, Cancer Lett, 252, 86, 10.1016/j.canlet.2006.12.012 · DOI · Paper page
  39. 2007, Cancer Metastasis Rev, 26, 737, 10.1007/s10555-007-9087-6 · DOI
  40. 1999, Hum Cell, 12, 197
  41. 2005, Carcinogenesis, 26, 513
  42. 2008, J Cell Biochem, 104, 1587, 10.1002/jcb.21652 · DOI
  43. 2009, Cancer Sci, 100, 419, 10.1111/j.1349-7006.2008.01064.x · doi:10.1111/j.1349-7006.2008.01064.x
  44. 1997, Int J Cancer, 71, 257, 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D · doi:10.1002/(sici)1097-0215(19970410)71:2<257::aid-ijc22>3.0.co;2-d

Cited by

See all 147

Metadata

Authors
Fridlender, Z. G., Kapoor, V., Buchlis, G., Cheng, G., Sun, J., Wang, L.-C. S., Singhal, S., Snyder, L. A., & Albelda, S. M.
Venue
American Journal of Respiratory Cell and Molecular Biology
Published
2011-02
Volume
44
Issue
2
Pages
230-237
ISSN
  • 1044-1549 (ISSN-L)
  • 1535-4989
OpenAlex
W2025767721
Cited by
147
References
5
FWCI
3.86
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8 + Cells. https://app.cochat.ai/papers/10.1165/rcmb.2010-0080oc
The paper
Fridlender, Z. G., Kapoor, V., Buchlis, G., Cheng, G., Sun, J., Wang, L.-C. S., Singhal, S., Snyder, L. A., & Albelda, S. M. (2011). Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8 + Cells. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2010-0080oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.